AllianceBernstein’s Cabaletta Bio CABA Stock Holding History

AllianceBernstein’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Buy	+108,410	New	+$357K	﹤0.01%	3002
2025 Q2	–	Sell	-64,630	Closed	-$89.5K	–	3247
2025 Q1	$89.5K	Hold	64,630	–	–	﹤0.01%	3079
2024 Q4	$147K	Hold	64,630	–	–	﹤0.01%	3078
2024 Q3	$305K	Hold	64,630	–	–	﹤0.01%	2909
2024 Q2	$483K	Buy	64,630 +33,320	+106%	+$408K	﹤0.01%	2692
2024 Q1	$534K	Sell	31,310 -62,022	-66%	-$1.33M	﹤0.01%	2559
2023 Q4	$2.12M	Sell	93,332 -72,071	-44%	-$1.21M	﹤0.01%	1903
2023 Q3	$2.52M	Buy	165,403 +154,303	+1,390%	+$2.11M	﹤0.01%	1760
2023 Q2	$143K	Buy	+11,100	New	+$120K	﹤0.01%	3042

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

AllianceBernstein's CABA Position: Q2 2026 in Review

AllianceBernstein opened a new position in Cabaletta Bio (CABA) in Q2 2026: 108,410 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #3002 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in CABA as recently as Q1 2025.

AllianceBernstein first reported a position in CABA in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.52M in Q3 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

AllianceBernstein held 108,410 shares of Cabaletta Bio worth $292K as of Q2 2026.
Cabaletta Bio was a new AllianceBernstein position in Q2 2026.
Cabaletta Bio made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3002 holding.
AllianceBernstein first reported a position in Cabaletta Bio in Q2 2023 and has held it in 9 quarters since.
AllianceBernstein's Cabaletta Bio position peaked at $2.52M in Q3 2023.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.